Your browser doesn't support javascript.
loading
Genome-wide association study in essential tremor identifies three new loci.
Müller, Stefanie H; Girard, Simon L; Hopfner, Franziska; Merner, Nancy D; Bourassa, Cynthia V; Lorenz, Delia; Clark, Lorraine N; Tittmann, Lukas; Soto-Ortolaza, Alexandra I; Klebe, Stephan; Hallett, Mark; Schneider, Susanne A; Hodgkinson, Colin A; Lieb, Wolfgang; Wszolek, Zbigniew K; Pendziwiat, Manuela; Lorenzo-Betancor, Oswaldo; Poewe, Werner; Ortega-Cubero, Sara; Seppi, Klaus; Rajput, Alex; Hussl, Anna; Rajput, Ali H; Berg, Daniela; Dion, Patrick A; Wurster, Isabel; Shulman, Joshua M; Srulijes, Karin; Haubenberger, Dietrich; Pastor, Pau; Vilariño-Güell, Carles; Postuma, Ronald B; Bernard, Geneviève; Ladwig, Karl-Heinz; Dupré, Nicolas; Jankovic, Joseph; Strauch, Konstantin; Panisset, Michel; Winkelmann, Juliane; Testa, Claudia M; Reischl, Eva; Zeuner, Kirsten E; Ross, Owen A; Arzberger, Thomas; Chouinard, Sylvain; Deuschl, Günther; Louis, Elan D; Kuhlenbäumer, Gregor; Rouleau, Guy A.
Affiliation
  • Müller SH; 1 Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts University Kiel, Germany.
  • Girard SL; 2 Département des Sciences Fondamentales, Université du Québec à Chicoutimi, Saguenay, Canada.
  • Hopfner F; 3 Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Merner ND; 1 Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts University Kiel, Germany.
  • Bourassa CV; 3 Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Lorenz D; 4 Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
  • Clark LN; 3 Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Tittmann L; 5 University Children's Hospital, University of Würzburg, Würzburg, Germany.
  • Soto-Ortolaza AI; 6 Department of Pathology and Cell Biology, Taub Institute, Columbia University, New York City, NY, USA.
  • Klebe S; 7 Institute of Epidemiology, Christian-Albrechts University Kiel and Biobank POPGEN, Kiel, Germany.
  • Hallett M; 8 Department of Neuroscience and Neurology, Mayo Clinic, Florida, USA.
  • Schneider SA; 9 Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
  • Hodgkinson CA; 10 Department of Neurology, University Hospital Freiburg, Freiburg im Breisgau, Germany.
  • Lieb W; 11 NINDS Intramural Research Program, National Institutes of Health, Bethesda, MD, USA.
  • Wszolek ZK; 1 Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts University Kiel, Germany.
  • Pendziwiat M; 12 Department of Neurology, Ludwig-Maximilians-Universität München, Munich Germany.
  • Lorenzo-Betancor O; 13 NIAAA/NIH Bethesda MD, USA.
  • Poewe W; 7 Institute of Epidemiology, Christian-Albrechts University Kiel and Biobank POPGEN, Kiel, Germany.
  • Ortega-Cubero S; 8 Department of Neuroscience and Neurology, Mayo Clinic, Florida, USA.
  • Seppi K; 14 Department of Paediatric Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts University Kiel, Germany.
  • Rajput A; 15 Neurogenetics, Division of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain.
  • Hussl A; 16 Department of Neurology, Hospital Universitari Mutua de Terrassa, University of Barcelona, Barcelona, Spain.
  • Rajput AH; 17 Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
  • Berg D; 15 Neurogenetics, Division of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain.
  • Dion PA; 16 Department of Neurology, Hospital Universitari Mutua de Terrassa, University of Barcelona, Barcelona, Spain.
  • Wurster I; 17 Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
  • Shulman JM; 18 University of Saskatchewan and Saskatoon Health Region, Saskatoon, SK, Canada.
  • Srulijes K; 17 Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
  • Haubenberger D; 18 University of Saskatchewan and Saskatoon Health Region, Saskatoon, SK, Canada.
  • Pastor P; 1 Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts University Kiel, Germany.
  • Vilariño-Güell C; 3 Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Postuma RB; 19 Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany.
  • Bernard G; 20 Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
  • Ladwig KH; 21 Departments of Molecular and Human Genetics and Neuroscience, and Program in Developmental Biology, Baylor College of Medicine and Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, Texas, USA.
  • Dupré N; 19 Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany.
  • Jankovic J; 11 NINDS Intramural Research Program, National Institutes of Health, Bethesda, MD, USA.
  • Strauch K; 15 Neurogenetics, Division of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain.
  • Panisset M; 16 Department of Neurology, Hospital Universitari Mutua de Terrassa, University of Barcelona, Barcelona, Spain.
  • Winkelmann J; 22 Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • Testa CM; 3 Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Reischl E; 23 Department of Neurology, Montreal General Hospital, Montréal, QC, Canada.
  • Zeuner KE; 3 Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Ross OA; 24 Departments of Pediatrics, Neurology and Neurosurgery, division of Pediatric Neurology, Montreal Children's Hospital, Montreal, Canada.
  • Arzberger T; 25 Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
  • Chouinard S; 26 Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Universität, Munich, Germany.
  • Deuschl G; 27 Faculté de Médecine, Université Laval, CHU de Québec (Enfant-Jésus), Québec, QC, Canada.
  • Louis ED; 20 Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
  • Kuhlenbäumer G; 28 Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
  • Rouleau GA; 29 Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.
Brain ; 139(Pt 12): 3163-3169, 2016 12.
Article de En | MEDLINE | ID: mdl-27797806
ABSTRACT
We conducted a genome-wide association study of essential tremor, a common movement disorder characterized mainly by a postural and kinetic tremor of the upper extremities. Twin and family history studies show a high heritability for essential tremor. The molecular genetic determinants of essential tremor are unknown. We included 2807 patients and 6441 controls of European descent in our two-stage genome-wide association study. The 59 most significantly disease-associated markers of the discovery stage were genotyped in the replication stage. After Bonferroni correction two markers, one (rs10937625) located in the serine/threonine kinase STK32B and one (rs17590046) in the transcriptional coactivator PPARGC1A were associated with essential tremor. Three markers (rs12764057, rs10822974, rs7903491) in the cell-adhesion molecule CTNNA3 were significant in the combined analysis of both stages. The expression of STK32B was increased in the cerebellar cortex of patients and expression quantitative trait loci database mining showed association between the protective minor allele of rs10937625 and reduced expression in cerebellar cortex. We found no expression differences related to disease status or marker genotype for the other two genes. Replication of two lead single nucleotide polymorphisms of previous small genome-wide association studies (rs3794087 in SLC1A2, rs9652490 in LINGO1) did not confirm the association with essential tremor.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protein-Serine-Threonine Kinases / Tremblement essentiel / Alpha-Caténine / Étude d'association pangénomique / Coactivateur 1-alpha du récepteur gamma activé par les proliférateurs de peroxysomes Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Brain Année: 2016 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protein-Serine-Threonine Kinases / Tremblement essentiel / Alpha-Caténine / Étude d'association pangénomique / Coactivateur 1-alpha du récepteur gamma activé par les proliférateurs de peroxysomes Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Brain Année: 2016 Type de document: Article Pays d'affiliation: Allemagne